Clinical trial

A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Health Record

NCT06642272

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-10-10

PhasePHASE4

Study timeline

Study start (actual)2024-10-10Date precision: day

Registry last updated2026-09-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2unresolved

Heart Failureunresolved

Chronic Kidney Diseasesunresolved

Interventions

Empagliflozin 10 MGDRUG · verified · RxNorm: empagliflozin 10 MG

Dapagliflozin 10 MGDRUG · verified · RxNorm: dapagliflozin 10 MG

Sponsors & collaborators

Herlev and Gentofte Hospitallead sponsor

Mapped research locations

CopenhagenDenmark2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06642272 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.